(19)
(11) EP 1 311 505 A2

(12)

(88) Date of publication A3:
18.07.2002

(43) Date of publication:
21.05.2003 Bulletin 2003/21

(21) Application number: 01961664.8

(22) Date of filing: 17.08.2001
(51) International Patent Classification (IPC)7C07D 453/00
(86) International application number:
PCT/US0122/597
(87) International publication number:
WO 0201/6355 (28.02.2002 Gazette 2002/09)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 21.08.2000 US 226652 P
19.04.2001 US 284832 P

(71) Applicant: PHARMACIA & UPJOHN COMPANY
Kalamazoo,Michigan 49001 (US)

(72) Inventors:
  • MYERS, Jason, K.
    Kalamazoo, MI 49001 (US)
  • ROGERS, Bruce, N.
    Portage, MI 49024 (US)
  • GROPPI, Vincent, E., Jr.
    Kalamazoo, MI 49006 (US)
  • PIOTROWSKI, David, W.
    Portage, MI 49024 (US)
  • BODNAR, Alice, L.
    Kalamazoo, MI 49006 (US)
  • JACOBSEN, Eric, Jon
    Richland, MI 49083 (US)
  • CORBETT, Jeffrey, W.
    Portage, MI 49024 (US)

(74) Representative: Perry, Robert Edward 
GILL JENNINGS & EVERYBroadgate House7 Eldon Street
London EC2M 7LH
London EC2M 7LH (GB)

   


(54) QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE ( NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS )